Cite
Toogeh G, Faranoush M, Razavi SM, et al. A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial. Int J Hematol Oncol Stem Cell Res. 2018;12(2):84-91
Toogeh, G., Faranoush, M., Razavi, S. M., Jalaeikhoo, H., Allahyari, A., Ravanbod, M. R., Zarrabi, F., Fallahazad, V., Rezaei Darzi, E., & Alizadeh Fard, S. S. (2018). A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial. International journal of hematology-oncology and stem cell research, 12(2), 84-91.
Toogeh, Gholamreza, et al. "A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial." International journal of hematology-oncology and stem cell research vol. 12,2 (2018): 84-91.
Toogeh G, Faranoush M, Razavi SM, Jalaeikhoo H, Allahyari A, Ravanbod MR, Zarrabi F, Fallahazad V, Rezaei Darzi E, Alizadeh Fard SS. A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial. Int J Hematol Oncol Stem Cell Res. 2018 Apr 01;12(2):84-91. PMID: 30233768; PMCID: PMC6141434.
Copy
Download .nbib